Live Breaking News & Updates on Head Of The Heart Failure Research Group

Stay updated with breaking news from Head of the heart failure research group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hyloris Expands Cardiovascular Pipeline with Breakthrough

Patient-friendly alternative to continuous IV administration – proven safety and efficacyTargeting orphan, late-stage heart failure indication with high. ....

United States , Marieke Vermeersch , Stijn Van Rompay , David Kaye , Baker Institute , American Heart Association , Department Of Cardiology , Drug Designation Program , York Heart Association , Hyloris Pharmaceuticals , View Research Inc , Centers For Disease Control , Diabetes Institute , Diabetes Institute The Baker , Head Of The Heart Failure Research Group , Hyloris Pharmaceuticals Sa Euronext Brussels , Corporate Communications , Euronext Brussels , Baker Heart , Heart Failure Specialist , Heart Failure Research Group , Alfred Hospital , Van Rompay , Chief Executive Officer , Minnesota Living , Heart Failure Score ,

Hyloris Expands Cardiovascular Pipeline with Breakthrough Extended-Release Milrinone Capsule in ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Marieke Vermeersch , Stijn Van Rompay , David Kaye , Baker Institute , American Heart Association , Department Of Cardiology , Drug Designation Program , York Heart Association , Hyloris Pharmaceuticals , View Research Inc , Centers For Disease Control , Diabetes Institute , Diabetes Institute The Baker , Head Of The Heart Failure Research Group , Hyloris Pharmaceuticals Sa Euronext Brussels , Corporate Communications , Euronext Brussels , Baker Heart , Heart Failure Specialist , Heart Failure Research Group , Alfred Hospital , Van Rompay , Chief Executive Officer , Minnesota Living , Heart Failure Score ,